The purpose of the research is to better understand the motor behavior of individuals in health and disease. The specific purpose of this project is to identify if we can utilize a smartphone to diagnose different movement disorders and monitor their symptoms. A. Objectives 1. Estimate symptom severity of Essential tremor (ET), Parkinson's disease (PD), Huntington's disease (HD), Primary focal dystonia (PFD), spinocerebellar ataxia (SCA), and Functional movement disorders (FMD) using a smartphone-based application 2. Differentiate individuals with the different movement disorders from healthy controls based on features from the smartphone data 3. Differentiate individuals with a specific movement disorder from people with other movement disorders based on features from the smartphone data B. Hypotheses / Research Question(s) We hypothesize that we can estimate the severity of symptoms using a smartphone application and that, using those estimates, we can differentiate individuals with movement disorders from healthy controls and from people with other movement disorders.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
UPDRS-III (Unified Parkinson's Disease Rating Scale)
Timeframe: Will occur right after the consent received from patients during the first lab visit.
TETRAS-performance (The Essential Tremor Rating Assessment Scale)
Timeframe: Will occur right after the consent received from patients during the first lab visit.
Motor UHDRS for HD (Unified Huntington's Disease Rating Scale: Reliability and Consistency)
Timeframe: Will occur right after the consent received from patients during the first lab visit.
(UDRS) Unified Dystonia Rating Scale
Timeframe: Will occur right after the consent received from patients during the first lab visit.
(BARS) Brief Ataxia Rating Scale
Timeframe: Will occur right after the consent received from patients during the first lab visit.
(s-FMDRS) Simplified Functional Movement Disorders Rating Scale
Timeframe: Will occur right after the consent received from patients during the first lab visit.